Arrowhead Pharmaceuticals (Germany) Investor Sentiment

HDP1 Stock  EUR 18.61  1.18  5.96%   
Roughly 61% of Arrowhead Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Arrowhead Pharmaceuticals suggests that many traders are alarmed regarding Arrowhead Pharmaceuticals' prospects. The current market sentiment, together with Arrowhead Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Arrowhead Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Arrowhead Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Arrowhead daily returns and investor perception about the current price of Arrowhead Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
Arrowhead Pharmaceuticals PT Raised to 34.00 - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Arrowhead Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Arrowhead Pharmaceuticals shareholders have earned a 18 percent CAGR over the last five years - Simp...
Google News at Macroaxis
over six months ago at news.google.com         
Swelling losses havent held back gains for Arrowhead Pharmaceuticals shareholders since theyre ... -...
Google News at Macroaxis
over six months ago at news.google.com         
Arrowhead Pharmaceuticals A Leading Small-Cap Developer Of RNAi Therapy - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Arrowhead Pharmaceuticals, Inc. Shares Sold by Panagora Asset Management Inc. - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Arrowhead Pharmaceuticals, Inc. Director Sells 110792.66 in Stock - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Arrowhead Pharmaceuticals Shares Down 4.8 percent After Insider Selling - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Is Arrowhead Pharmaceuticals Inc Stock at the Top of the Biotechnology Industry - InvestorsObserver
Google News at Macroaxis
over six months ago at news.google.com         
Research Analysts Set Expectations for Arrowhead Pharmaceuticals, Inc.s FY2025 Earnings - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Arrowhead Pharmaceuticals, Inc. CEO Christopher Richard Anzalone Sells 9952 Shares - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Arrowhead Pharmaceuticals prices 450M common stock offering - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Arrowhead Pharmaceuticals, Inc. Receives Average Recommendation of Moderate Buy from ... - MarketBea...
Google News at Macroaxis
over six months ago at news.google.com         
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635 - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Arrowhead Pharmaceuticals Inc CEO Christopher Anzalone Sells 12,000 Shares - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Arrowhead Pharmaceuticals that are available to investors today. That information is available publicly through Arrowhead media outlets and privately through word of mouth or via Arrowhead internal channels. However, regardless of the origin, that massive amount of Arrowhead data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Arrowhead Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Arrowhead Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Arrowhead Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Arrowhead Pharmaceuticals alpha.

Arrowhead Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.15OctNovDec -100102030
JavaScript chart by amCharts 3.21.15Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals Dividend Benchmark Dow Jones Industrial
       Timeline  

Complementary Tools for Arrowhead Stock analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
CEOs Directory
Screen CEOs from public companies around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
News Freq…Investor S…